215 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 5 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KCNJ2Potassium inwardly-rectifying channel, subfamily J, member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNJ3Potassium inwardly-rectifying channel, subfamily J, member 3Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ5Potassium inwardly-rectifying channel, subfamily J, member 5Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNJ6Potassium inwardly-rectifying channel, subfamily J, member 6Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ8Potassium inwardly-rectifying channel, subfamily J, member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK16Potassium channel, subfamily K, member 16Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNK17Potassium channel, subfamily K, member 17Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK3Potassium channel, subfamily K, member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK5Potassium channel, subfamily K, member 5Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK6Potassium channel, subfamily K, member 6Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNN2Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNN4Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium voltage-gated channel, KQT-like subfamily, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel, KQT-like subfamily, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNQ4Potassium voltage-gated channel, KQT-like subfamily, member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNS2Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNS3Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNT2Potassium channel, subfamily T, member 2Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
LBPLipopolysaccharide binding proteinPlasma proteins
Predicted secreted proteins
Transporters
Group enriched
LHFPL5Lipoma HMGIC fusion partner-like 5Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
LRRC8ALeucine rich repeat containing 8 family, member ADisease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Expressed in all
LRRC8BLeucine rich repeat containing 8 family, member BPredicted membrane proteins
Transporters
Mixed
LRRC8CLeucine rich repeat containing 8 family, member CPredicted membrane proteins
Transporters
Mixed
LRRC8DLeucine rich repeat containing 8 family, member DPredicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
LRRC8ELeucine rich repeat containing 8 family, member EPredicted intracellular proteins
Predicted membrane proteins
Transporters
Mixed
MARVELD3MARVEL domain containing 3Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
MCL1Myeloid cell leukemia 1Cancer-related genes
Mitochondrial proteins
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
MCOLN1Mucolipin 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Expressed in all
MCOLN2Mucolipin 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
MS4A1Membrane-spanning 4-domains, subfamily A, member 1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
MS4A10Membrane-spanning 4-domains, subfamily A, member 10Predicted membrane proteins
Transporters
Group enriched
MYADMMyeloid-associated differentiation markerPredicted membrane proteins
Transporters
Expressed in all
NALCNSodium leak channel, non-selectiveDisease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
NPPCNatriuretic peptide CPredicted secreted proteins
Transporters
Tissue enhanced
NSFN-ethylmaleimide-sensitive factorEnzymes
Predicted intracellular proteins
Transporters
Tissue enriched
ORAI1ORAI calcium release-activated calcium modulator 1Disease related genes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Expressed in all
ORAI3ORAI calcium release-activated calcium modulator 3Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
P2RX3Purinergic receptor P2X, ligand-gated ion channel, 3Predicted membrane proteins
Transporters
Tissue enhanced
P2RX4Purinergic receptor P2X, ligand-gated ion channel, 4Predicted membrane proteins
Transporters
Mixed
P2RX7Purinergic receptor P2X, ligand-gated ion channel, 7Predicted membrane proteins
Transporters
Mixed
PANX1Pannexin 1Predicted membrane proteins
Transporters
Expressed in all
PANX2Pannexin 2Predicted membrane proteins
Transporters
Tissue enhanced
PDYNProdynorphinDisease related genes
Potential drug targets
Predicted secreted proteins
Transporters
Tissue enriched
PENKProenkephalinPlasma proteins
Predicted secreted proteins
Transporters
Group enriched
PIEZO1Piezo-type mechanosensitive ion channel component 1Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
PIEZO2Piezo-type mechanosensitive ion channel component 2Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mixed
PKD1Polycystic kidney disease 1 (autosomal dominant)Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
PKD1L1Polycystic kidney disease 1 like 1Plasma proteins
Predicted membrane proteins
Transporters
Mixed
PKD2Polycystic kidney disease 2 (autosomal dominant)Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Expressed in all
PKD2L1Polycystic kidney disease 2-like 1Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced

« prev | Page of 5 | next »